Fig. 2From: Impact of the COVID-19 pandemic on access to the cerliponase alfa managed access agreement in England for CLN2 treatmentImpact of the COVID-19 pandemic on children with CLN2 disease and their families. BDFA, Batten Disease Family Association; GOSH, Great Ormond Street Hospital (London); MAA, managed access schemeBack to article page